```html

Jaundice due to Hepatitis A

Overview

Jaundice is the yellow discoloration of the skin, sclerae (the whites of the eyes), and other tissues caused by an excess of bilirubin in the bloodstream. When jaundice occurs as a result of hepatitis A, it reflects inflammation of the liver caused by infection with the hepatitis A virus (HAV). HAV is a highly contagious, fecal‑oral pathogen that primarily affects the liver’s ability to process bilirubin.

Hepatitis A is most common in areas with limited access to clean water and sanitation, but outbreaks also happen in high‑income countries through contaminated food, water, or close personal contact.

• Globally, the World Health Organization estimates ≈ 1.4 million cases of acute hepatitis A each year.
• In the United States, the CDC reported an average of ≈ 3,000 cases per year (2015‑2020), with occasional spikes linked to food‑borne outbreaks.
• Children under 10 are more likely to develop an asymptomatic infection, whereas adults frequently experience jaundice and more severe symptoms.

Although hepatitis A is usually self‑limited and does not become chronic, the accompanying jaundice can be alarming and may require medical monitoring.

Symptoms

Symptoms usually appear **2–6 weeks** after exposure (the incubation period). Not everyone will develop jaundice; however, when it occurs it is typically part of a broader symptom set.

General Symptoms

• Fatigue – persistent tiredness, often the first sign.
• Loss of appetite – may lead to weight loss.
• Nausea & vomiting – occasional mild to moderate.
• Abdominal discomfort – usually in the right upper quadrant (where the liver sits).
• Low‑grade fever – 37.8–38.5 °C (100–101.5 °F).

Jaundice‑Specific Signs

• Yellow skin and eyes – most noticeable on the palms, soles, and inner eyelids.
• Dark urine – due to excreted bilirubin.
• Pale, clay‑colored stools – bilirubin not reaching the intestines.
• Itching (pruritus) – caused by bilirubin deposition in skin.

Other Possible Features

• Right‑sided shoulder pain (referred pain from liver capsule irritation).
• Joint or muscle aches.
• Transient rash (rare).

Symptoms typically last 2–6 weeks, with jaundice resolving as liver function improves.

Causes and Risk Factors

Primary Cause

Hepatitis A is caused by the hepatitis A virus, a non‑enveloped, single‑stranded RNA virus of the Picornaviridae family. The virus replicates in hepatocytes (liver cells) and triggers an immune response that results in liver inflammation and impaired bilirubin processing.

Transmission Routes

• Fecal‑oral ingestion of contaminated food or water (most common).
• Person‑to‑person contact, especially in households or daycare settings.
• Travel to endemic regions without proper water/food precautions.
• Food‑borne outbreaks linked to raw shellfish, salads, or frozen berries.
• Blood products – very rare due to inactivation during processing.

Risk Factors

• Living in or traveling to areas with poor sanitation (e.g., parts of Asia, Africa, Central and South America).
• Working in food‑handling or childcare professions without adequate hand hygiene.
• Men who have sex with men (MSM) and individuals with multiple sexual partners (fecal‑oral exposure).
• Travelers who consume untreated water, ice, or uncooked produce.
• Not being vaccinated against hepatitis A (effective vaccine available since the 1990s).

Diagnosis

Diagnosis combines clinical assessment (presence of jaundice and compatible symptoms) with laboratory testing to confirm HAV infection and evaluate liver function.

Liver Function Tests (LFTs)

• Serum bilirubin – often markedly elevated (total bilirubin >2 mg/dL).
• Alanine aminotransferase (ALT) & Aspartate aminotransferase (AST) – typically 10‑30× normal, indicating acute hepatocellular injury.
• Alkaline phosphatase (ALP) & Gamma‑glutamyl transferase (GGT) – may be mildly elevated.

Serologic Tests for HAV

• IgM anti‑HAV antibodies – appear early (within 2‑3 weeks of exposure) and indicate acute infection.
• IgG anti‑HAV antibodies – develop later and confer lifelong immunity; useful for assessing past exposure or vaccination status.

Additional Tests (when needed)

• Complete blood count (CBC) – may show mild leukopenia or thrombocytopenia.
• Coagulation profile (PT/INR) – to assess liver synthetic function; severe cases may show prolongation.
• Ultrasound of the abdomen – to rule out gallstones or biliary obstruction when diagnosis is uncertain.

Diagnosis is usually straightforward; most clinicians can confirm hepatitis A within a single outpatient visit.

Treatment Options

There is **no specific antiviral medication** for hepatitis A. Management is supportive and focuses on relieving symptoms, preventing complications, and supporting liver recovery.

Supportive Care

• Hydration – oral rehydration solutions or intravenous fluids for those unable to maintain intake.
• Rest – adequate sleep reduces metabolic demand on the liver.
• Nutritional support – a balanced diet low in fatty, fried, or heavily spiced foods; small frequent meals are better tolerated.
• Antiemetics (e.g., ondansetron) for persistent nausea/vomiting.
• Pruritus relief – cholestyramine, antihistamines, or topical moisturizers.

Medications Not Recommended

• Acetaminophen in high doses – can further stress the liver; limit to ≤2 g/day if needed.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – avoid if severe liver inflammation or coagulopathy is present.

Hospitalization

Hospital care is rarely needed, but indications include:

• Severe dehydration.
• Marked coagulopathy (INR >1.5) or encephalopathy.
• Profound jaundice with bilirubin >20 mg/dL.
• Underlying liver disease (e.g., chronic hepatitis B/C, cirrhosis).

Follow‑up

Most patients have a full recovery within 2–3 months. Repeat LFTs are usually performed 2–4 weeks after symptom onset to ensure a downward trend.

Living with Jaundice due to Hepatitis A

Daily Management Tips

• Stay hydrated – aim for 2–3 L of water or oral rehydration solution daily.
• Balanced diet – prioritize lean proteins (chicken, fish, beans), whole grains, and cooked vegetables. Avoid raw or undercooked shellfish and unpasteurized dairy.
• Limit alcohol – alcohol is metabolized by the liver and can worsen injury; abstain until LFTs normalize.
• Monitor bilirubin – note changes in skin or eye color; photographing can help track trends.
• Rest – schedule light activity; avoid heavy lifting or vigorous exercise until energy returns.
• Medication safety – keep a list of all over‑the‑counter meds and supplements; discuss any new drug with your clinician.
• Hygiene – wash hands with soap for at least 20 seconds after bathroom use and before handling food to prevent spread to household members.

Emotional Well‑being

Jaundice can be socially distressing. Consider:

• Talking with friends or a support group.
• Seeking counseling if anxiety about contagion or work absence arises.
• Educating family members about transmission prevention.

Prevention

Vaccination

The hepatitis A vaccine is >95 % effective after two doses given 6–12 months apart. CDC recommends vaccination for:

• All travelers to endemic regions.
• Children ≥1 year old in the U.S. (routine childhood series).
• People with chronic liver disease, clotting‑factor disorders, or who are immunocompromised.
• Men who have sex with men and persons who use illicit drugs.

Safe Food & Water Practices

• Drink bottled or treated water; avoid ice cubes in unknown sources.
• Peel fruits and vegetables yourself; wash produce with clean water.
• Cook shellfish (especially oysters, clams, mussels) thoroughly.
• Reheat leftovers to ≥ 75 °C (165 °F).

Hand Hygiene & Sanitation

• Wash hands with soap and water after using the toilet, changing diapers, or caring for a sick person.
• Use alcohol‑based hand sanitizer when soap is unavailable, but remember it does **not** eliminate HAV on contaminated surfaces.
• Disinfect kitchen surfaces with a bleach solution (1 tbsp bleach per 1 L water) after handling raw foods.

Complications

Although most cases are self‑limited, untreated or severe cases can lead to complications:

• Acute liver failure – rare (≈0.3 % of cases) but life‑threatening; may necessitate transplant.
• Prolonged cholestasis – bilirubin remains elevated > 12 weeks, causing persistent itching and fatigue.
• Coagulopathy – impaired clotting increasing bleeding risk.
• Renal dysfunction – especially in older adults or those with dehydration.
• Secondary bacterial infections – due to compromised immunity.

When to Seek Emergency Care

References

• World Health Organization. Hepatitis A Fact Sheet. 2022.
• Centers for Disease Control and Prevention. Hepatitis A – Epidemiology & Prevention. Updated 2024.
• Mayo Clinic. Hepatitis A – Symptoms and Causes. 2023.
• Cleveland Clinic. Jaundice: Causes, Diagnosis, and Treatment. 2024.
• U.S. National Library of Medicine. Hepatitis A Virus Infection. PubMed Review, 2023.

```